Aldeyra Therapeutics: Q1 Earnings Insights


Aldeyra Therapeutics ALDX reported its Q1 earnings results on Thursday, May 5, 2022 at 07:00 AM.

Here's what investors need to know about the announcement.


Aldeyra Therapeutics beat estimated earnings by 6.45%, reporting an EPS of $-0.29 versus an estimate of $-0.31.

Revenue was down $0.00 from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.01 which was followed by a 1.85% increase in the share price the next day.


To track all earnings releases for Aldeyra Therapeutics visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Posted In: BZI-RecapsEarningsNews